EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Thrombin generation test as a useful tool for improving disease severity stratification in antiphospholipid syndrome

Cecile Yelnik iD, Anne Bauters, Julien Labreuche, Maximilien Desvages, David Launay, Eric Hachulla, Sylvain Dubucquoi, Steve Lancel, Marie Frimat, Marc Lambert

RMD Open · 2025

DOI: 10.1136/rmdopen-2025-005489 ↗

Kurz gefasst

Fachartikel in der Zeitschrift RMD Open, 2025. Verfasst von Cecile Yelnik und 9 weiteren Autor:innen. Beteiligte Einrichtung: Département de Médecine Interne et d'Immunologie Clinique, Centre de référence des Maladies Auto-Immunes et Auto-inflammatoires Systémiques rares de …. Hauptthemen laut MEDLINE: Antiphospholipid Syndrome, Thrombin, Thrombosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with antiphospholipid syndrome (APS) display a wide range of clinical manifestations with similar immunological profile with the presence of lupus anticoagulant in around 70% of them. Although antiphospholipid antibodies (aPL) profile influences the risk of thrombosis in APS, APS risk stratification remains to be improved.

Objectives

Our study aimed to evaluate thrombin generation test (TGT) interest to improve disease severity stratification in APS patients. Patients/methods In this monocentric, transversal study, we included unselected primary thrombotic APS patients, fulfilling APS classification criteria and treated by vitamin K antagonist (VKA). 28 non-APS patients under VKA followed in our hospital were included as controls. TGT was performed on plasma samples with the calibrated automated thrombogram in our core laboratory.

Results

Between January 2020 and March 2023, 114 thrombotic APS patients (without systemic lupus erythematosus) were included (female 71 (62.3%), mean age 50±14 years old, median duration since the last APS event of 51 months (IQR 23–129 months)). APS patients had prolonged lag time (LT) and time to peak (TTP) compared with anticoagulated controls. History of relapse, catastrophic APS (CAPS), all aPL positivities and elevated Bb fragments were strongly associated with a prolonged LT and TTP.

Conclusions

Our findings suggest that APS patients under VKA had significantly prolonged TGT times compared with anticoagulated controls, with the greatest prolongations in patients with history of relapse or CAPS. Thus, TGT might be a useful tool to improve APS disease severity stratification without temporary cessation of VKA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiphospholipid SyndromeThrombinThrombosisHumansFemaleMaleMiddle AgedSeverity of Illness IndexAdultAntibodies, AntiphospholipidBlood Coagulation TestsCross-Sectional StudiesAgedLupus Coagulation InhibitorBiomarkers

Stichwörter der Autor:innen

Antiphospholipid AntibodiesAntiphospholipid SyndromeThrombosis

Substanzen

ThrombinAntibodies, AntiphospholipidLupus Coagulation InhibitorBiomarkers

Autor:innen und Institutionen

  • Département de Médecine Interne et d'Immunologie Clinique, Centre de référence des Maladies Auto-Immunes et Auto-inflammatoires Systémiques rares de l'Adulte du Nord, Nord-Ouest, Méditerranée et Guadeloupe (CeRAINOM), E…
  • RID-AGE - Facteurs de risque et déterminants moléculaires des maladies liées au vieillissement, INSERM U1167, Lille, France.
  • Institut d'Hématologie-Transfusion, Centre de biologie Pathologie, Lille University Hospital, CHU Lille, Lille, France.
  • ULR 2694 - METRICS: Évaluation des technologies de santé et des pratiques médicales, Lille University Hospital, CHU Lille, Lille, France.
  • Immunologie, Centre de biologie Pathologie, Lille University Hospital, CHU Lille, Lille, France.
  • Département de Néphrologie, Lille University Hospital, CHU Lille, Lille, France.

ORCID-Profile: Cecile Yelnik

Zitieren

APA

Yelnik, C., Bauters, A., Labreuche, J., Desvages, M., Launay, D., Hachulla, E., Dubucquoi, S., Lancel, S., Frimat, M., & Lambert, M. (2025). Thrombin generation test as a useful tool for improving disease severity stratification in antiphospholipid syndrome. RMD Open. https://doi.org/10.1136/rmdopen-2025-005489

Vancouver

Yelnik C, Bauters A, Labreuche J, Desvages M, Launay D, Hachulla E, et al. Thrombin generation test as a useful tool for improving disease severity stratification in antiphospholipid syndrome. RMD Open. 2025. doi:10.1136/rmdopen-2025-005489

BibTeX
@article{Yelnik2025,
  author = {Yelnik, Cecile and Bauters, Anne and Labreuche, Julien and Desvages, Maximilien and Launay, David and Hachulla, Eric and Dubucquoi, Sylvain and Lancel, Steve and Frimat, Marie and Lambert, Marc},
  title = {Thrombin generation test as a useful tool for improving disease severity stratification in antiphospholipid syndrome},
  journal = {RMD Open},
  year = {2025},
  doi = {10.1136/rmdopen-2025-005489}
}
Kostenlos starten →